The ADAMTS6 expression did not significantly affect the overall survival of NSCLC patients without the histopathological subtype division (p = 0.4622) or the adenocarcinoma patients (p = 0.2618). The gene discussed is ADAMTS6; the disease is adenocarcinoma.